Semiconductor and sensor maker Silicone Microstructures (SMI) has inked a deal with Hamburg University of Technology and University Hospital Hamburg-Eppendorf to research wireless tumor sensor implants.
The Milpitas, Calif.-based company said that the use of wireless sensors could improve the efficiency and optimization of chemotherapy for cancer treatment.
SMI said that it is working with Dr. Wolfgang Krautschneider, . Dr. Udo Schumacher and Dr. Christine Stürken to conduct research into the sensors, which will measure pressure and temperature at the point of interest. That data will be wirelessly transmitted back to the medical team, the company said.
The company said that an ultra-small sensor implanted into the tumor tissue could help oncologists adjust chemotherapy treatment according to the conditions within the tumor.
SMI produces the IntraSense line of pressure sensing solutions, and touted that they are designed to enable accurate in vivo pressure sensing in a number of minimally invasive devices, including catheters and endoscopes.
“SMI is excited to be part of this project. The complementary competencies of the medical team around Prof. Dr. Krautschneider and SMI’s sensor experts opens up new possibilities for diagnostic and therapeutic concepts. This is just one example of the many ways IntraSense is enabling new life saving devices and treatment methods and is a key driver for SMI’s ongoing innovation,” SMI IntraSense products VP Dr. Justin Gaynor said in a press release.
DeviceTalks Minnesota's leadership track is designed to provide attendees with insights on topics such as:
Use code SAVE15 to save 15%!